SEMLER SCIENTIFIC DL-001
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more
SEMLER SCIENTIFIC DL-001 (6FA) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SEMLER SCIENTIFIC DL-001 (6FA) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SEMLER SCIENTIFIC DL-001 - Net Assets Trend (None–None)
This chart illustrates how SEMLER SCIENTIFIC DL-001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SEMLER SCIENTIFIC DL-001 (None–None)
The table below shows the annual net assets of SEMLER SCIENTIFIC DL-001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SEMLER SCIENTIFIC DL-001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SEMLER SCIENTIFIC DL-001 Competitors by Market Cap
The table below lists competitors of SEMLER SCIENTIFIC DL-001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ShaMaran Petroleum Corp
PINK:SHASF
|
$262.48 Million |
|
Longxing Chemical Stock Co Ltd
SHE:002442
|
$262.50 Million |
|
Satellogic V Inc
NASDAQ:SATL
|
$262.55 Million |
|
First Copper Technology Co Ltd
TW:2009
|
$262.55 Million |
|
CARsgen Therapeutics Holdings Limited
PINK:CRTHF
|
$262.40 Million |
|
AXISCADES Technologies Limited
NSE:AXISCADES
|
$262.35 Million |
|
Jayaswal Neco Industries Limited
NSE:JAYNECOIND
|
$262.35 Million |
|
Solaris Resources Inc.
OTCQB:SLSR
|
$262.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SEMLER SCIENTIFIC DL-001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SEMLER SCIENTIFIC DL-001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SEMLER SCIENTIFIC DL-001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SEMLER SCIENTIFIC DL-001's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SEMLER SCIENTIFIC DL-001 (6FA) | €- | N/A | N/A | $262.41 Million |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| Global Bioenergies SA (1DK) | $14.81 Million | -86.04% | 0.89x | $369.68K |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| 2invest AG (2INV) | $82.61 Million | -2.29% | 0.06x | $13.67 Million |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |